110 related articles for article (PubMed ID: 27466498)
1. Protein-bound Polysaccharide-K Inhibits Hedgehog Signaling Through Down-regulation of MAML3 and RBPJ Transcription Under Hypoxia, Suppressing the Malignant Phenotype in Pancreatic Cancer.
Yamasaki A; Onishi H; Imaizumi A; Kawamoto M; Fujimura A; Oyama Y; Katano M
Anticancer Res; 2016 Aug; 36(8):3945-52. PubMed ID: 27466498
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.
Onishi H; Yamasaki A; Kawamoto M; Imaizumi A; Katano M
Cancer Lett; 2016 Feb; 371(2):143-50. PubMed ID: 26655998
[TBL] [Abstract][Full Text] [Related]
3. RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung Cancer.
Onishi H; Ichimiya S; Yanai K; Umebayashi M; Nakamura K; Yamasaki A; Imaizumi A; Nagai S; Murahashi M; Ogata H; Morisaki T
Anticancer Res; 2018 Aug; 38(8):4543-4547. PubMed ID: 30061220
[TBL] [Abstract][Full Text] [Related]
4. Protein-bound polysaccharide decreases invasiveness and proliferation in pancreatic cancer by inhibition of hedgehog signaling and HIF-1α pathways under hypoxia.
Onishi H; Morisaki T; Nakao F; Odate S; Morisaki T; Katano M
Cancer Lett; 2013 Jul; 335(2):289-98. PubMed ID: 23485726
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
Li W; Cao L; Chen X; Lei J; Ma Q
Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer.
Onishi H; Kai M; Odate S; Iwasaki H; Morifuji Y; Ogino T; Morisaki T; Nakashima Y; Katano M
Cancer Sci; 2011 Jun; 102(6):1144-50. PubMed ID: 21338440
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer.
Onishi H; Morifuji Y; Kai M; Suyama K; Iwasaki H; Katano M
Cancer Sci; 2012 Jul; 103(7):1272-9. PubMed ID: 22486854
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells.
Xu Y; An Y; Wang X; Zha W; Li X
Oncol Rep; 2014 Feb; 31(2):707-12. PubMed ID: 24297612
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
10. Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway.
Shinbo T; Fushida S; Tsukada T; Harada S; Kinoshita J; Oyama K; Okamoto K; Ninomiya I; Takamura H; Kitagawa H; Fujimura T; Yashiro M; Hirakawa K; Ohta T
Oncol Rep; 2015 Feb; 33(2):553-8. PubMed ID: 25435013
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts.
Walter K; Omura N; Hong SM; Griffith M; Vincent A; Borges M; Goggins M
Clin Cancer Res; 2010 Mar; 16(6):1781-9. PubMed ID: 20215540
[TBL] [Abstract][Full Text] [Related]
12. Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in Tumor-bearing Mouse Models.
Konagai A; Yoshimura K; Hazama S; Yamamoto N; Aoki K; Ueno T; Fujioka M; Iijima H; Kato M; Uchida M; Wada T; Inoue M; Asao T; Fuse M; Wada S; Kuramasu A; Kamei R; Takeda S; Yamamoto S; Yoshino S; Oka M; Nagano H
Anticancer Res; 2017 Aug; 37(8):4093-4101. PubMed ID: 28739693
[TBL] [Abstract][Full Text] [Related]
13. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.
Feldmann G; Fendrich V; McGovern K; Bedja D; Bisht S; Alvarez H; Koorstra JB; Habbe N; Karikari C; Mullendore M; Gabrielson KL; Sharma R; Matsui W; Maitra A
Mol Cancer Ther; 2008 Sep; 7(9):2725-35. PubMed ID: 18790753
[TBL] [Abstract][Full Text] [Related]
14. RBPJ inhibition impairs the growth of lung cancer.
Lv Q; Shen R; Wang J
Tumour Biol; 2015 May; 36(5):3751-6. PubMed ID: 25589461
[TBL] [Abstract][Full Text] [Related]
15. Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma.
Heynen GJ; Nevedomskaya E; Palit S; Jagalur Basheer N; Lieftink C; Schlicker A; Zwart W; Bernards R; Bajpe PK
Mol Cancer Res; 2016 May; 14(5):411-22. PubMed ID: 26785999
[TBL] [Abstract][Full Text] [Related]
16. Hedgehog signaling regulates PDL-1 expression in cancer cells to induce anti-tumor activity by activated lymphocytes.
Onishi H; Fujimura A; Oyama Y; Yamasaki A; Imaizumi A; Kawamoto M; Katano M; Umebayashi M; Morisaki T
Cell Immunol; 2016 Dec; 310():199-204. PubMed ID: 27522179
[TBL] [Abstract][Full Text] [Related]
17. MAML3 Contributes to Induction of Malignant Phenotype of Gallbladder Cancer Through Morphogenesis Signalling Under Hypoxia.
Na L; Onishi H; Morisaki S; Ichimiya S; Yamada Y; Masuda S; Nagao S; Koga S; Nakayama K; Imaizumi A; Oda Y; Nakamura M
Anticancer Res; 2023 Jul; 43(7):2909-2922. PubMed ID: 37351966
[TBL] [Abstract][Full Text] [Related]
18. Sedum sarmentosum Bunge extract induces apoptosis and inhibits proliferation in pancreatic cancer cells via the hedgehog signaling pathway.
Bai Y; Chen B; Hong W; Liang Y; Zhou M; Zhou L
Oncol Rep; 2016 May; 35(5):2775-84. PubMed ID: 26987050
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M
Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653
[TBL] [Abstract][Full Text] [Related]
20. Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway.
Subramani R; Gonzalez E; Nandy SB; Arumugam A; Camacho F; Medel J; Alabi D; Lakshmanaswamy R
Oncotarget; 2017 Feb; 8(7):10891-10904. PubMed ID: 26988754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
